Photodynamic therapy (PDT) is an emerging minimally invasive treatment that can be employed in many human diseases including prostate cancer. This treatment of human prostate cancer depends on the localization of a drug (photosensitizer) into the prostate. The photosensitizer is activated by high- energy laser light and the active drug destroys cancerous tissue. The success of PDT depends on precise placement of light diffusers in the prostate. Since the prostate is irregular in shape, with different dimensions, a transurethral light delivery that is circular in distribution cannot be used in most cases of carcinoma of the prostate. Sources of light and their spatial distribution must be tailored to each individual patient. More uniform, therapeutic light distribution can be achieved by interstitial light irradiation. In this case, the light is delivered by diffusers placed within the substance of the prostate parallel to the urethra at a distance optimized to deliver adequate levels of light and to create the desired photodynamic effect. For this reason, we are developing a computer program that can calculate the distribution of energy depending on the number of light sources placed in the prostate, their position in the gland, the dimension of the prostate, and the attenuation coefficient. A patient's three-dimensional prostate model is built based on ultrasound images. Then the program is being designated to predict the best set of parameters and position of light diffusers in space, displays them in graphical form or in numerical form. The program is amenable for interfacing with robotic treatment systems.
[1]
S. Marcus,et al.
Photodynamic therapy of human cancer
,
1992,
Proc. IEEE.
[2]
Shi-Chung Chang,et al.
Interstitial and transurethral photodynamic therapy of the canine prostate using meso‐tetra‐(m‐hydroxyphenyl) chlorin
,
1996,
International journal of cancer.
[3]
C J Gomer,et al.
Photodynamic therapy in the treatment of malignancies.
,
1989,
Seminars in hematology.
[4]
R. Keck,et al.
Transperineal photodynamic ablation of the canine prostate.
,
1996,
The Journal of urology.
[5]
J. Damber,et al.
Pressure-flow studies before and after transurethral microwave thermotherapy of benign prostatic hyperplasia using low- and high-energy protocols.
,
1998,
British journal of urology.
[6]
B. Wilson,et al.
Changes in in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy.
,
1997,
Radiation research.
[7]
J Roy,et al.
Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma.
,
1996,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.